Evidence regarding clinical use of microvolt T-wave alternans
Background: Microvolt T-wave alternans (MTWA) testing in many studies has proven to be a highly accurate predictor of ventricular tachyarrhythmic events (VTEs) in patients with risk factors for sudden cardiac death (SCD) but without a prior history of sustained VTEs (primary prevention patients)....
Main Authors: | Hohnloser, Stefan H., Ikeda, Takanori, Cohen, Richard J. |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2011
|
Online Access: | http://hdl.handle.net/1721.1/61763 https://orcid.org/0000-0002-5573-0137 |
Similar Items
-
Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients
by: Cohen, Richard J., et al.
Published: (2013) -
Microvolt T-wave alternans testing provides a reliable means of guiding anti-arrhythmic therapy
by: Hohnloser, Stefan H., et al.
Published: (2013) -
Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death
by: Merchant, Faisal M., et al.
Published: (2016) -
P-wave electrical alternans as an indicator of paroxysmal atrial fibrillation
by: Iyengar, Nikhil, 1969-
Published: (2012) -
Relating cardiac electrical and mechanical alternans to ventricular stability
by: Clancy, Edward Arthur
Published: (2012)